USA - engelska - NLM (National Library of Medicine)

american regent, inc. - indigotindisulfonate sodium (unii: d3741u8k7l) (indigotindisulfonic acid - unii:x7oi7jf73p) - indigotindisulfonate sodium 8 mg in 1 ml - originally employed as a kidney function test, the chief application of indigo carmine at present is localizing ureteral orifices during cystoscopy and ureteral catheterization. indigo carmine is contraindicated in patients who have previously experienced an adverse reaction following its use. indigo carmine is not a controlled substance listed in any of the drug enforcement administration schedules. its use is not known to lead to dependence or abuse.

USA - engelska - NLM (National Library of Medicine)

american regent, inc. - buprenorphine hydrochloride (unii: 56w8mw3en1) (buprenorphine - unii:40d3scr4gz) - buprenorphine 0.324 mg in 1 ml - buprenorphine hydrochloride injection is indicated for the management of pain severe enough to require an opioid analgesic and for which alternate treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see warnings: addiction, abuse, and misuse] reserve buprenorphine hydrochloride injection for use in patients for whom alternative treatment options [e.g., non-opioid analgesics or opioid combination products]: - have not been tolerated, or are not expected to be tolerated, have not been tolerated, or are not expected to be tolerated, - have not provided adequate analgesia, or are not expected to provide adequate analgesia. buprenorphine hydrochloride injection is contraindicated in patients with: - significant respiratory depression [see warnings]. significant respiratory depression [see warnings]. - acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings

USA - engelska - NLM (National Library of Medicine)

american regent, inc. - calcium gluconate monohydrate (unii: czn0mi5r31) (calcium - unii:sy7q814vup) - calcium gluconate is used to treat conditions arising from calcium deficiencies such as hypocalcemic tetany, hypocalcemia related to hypoparathyroidism and hypocalcemia due to rapid growth or pregnancy. it is also used in the treatment of black widow spider bites to relieve muscle cramping and as an adjunct in the treatment of rickets, osteomalacia, lead colic and magnesium sulfate overdosage. calcium gluconate has also been employed to decrease capillary permeability in allergic conditions, nonthrombocytopenic purpura and exudative dermatoses such as dermatitis herpetiformis and for pruritus of eruptions caused by certain drugs. in hyperkalemia, calcium gluconate may aid in antagonizing the cardiac toxicity provided the patient is not receiving digitalis therapy. calcium salts are contraindicated in patients with ventricular fibrillation or hypercalcemia. intravenous administration of calcium is contraindicated when serum calcium levels are above normal. if neonates are required, or expected to require, trea

USA - engelska - NLM (National Library of Medicine)

american regent, inc. - ofloxacin (unii: a4p49jaz9h) (ofloxacin - unii:a4p49jaz9h) - ofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: ofloxacin ophthalmic solution is contraindicated in patients with a history of hypersensitivity to ofloxacin, to other quinolones, or to any of the components in this medication.

USA - engelska - NLM (National Library of Medicine)

american regent, inc. - manganese sulfate (unii: w00lys4t26) (manganese cation (2+) - unii:h6ep7w5457) - manganese sulfate injection, usp is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition (tpn). administration helps to maintain plasma levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms. manganese sulfate injection, usp should not be given undiluted by direct injection into a peripheral vein because of the potential for infusion phlebitis.

USA - engelska - NLM (National Library of Medicine)

american regent, inc. - betamethasone acetate (unii: ti05ao53l7) (betamethasone - unii:9842x06q6m), betamethasone sodium phosphate (unii: 7bk02scl3w) (betamethasone - unii:9842x06q6m) - when oral therapy is not feasible, the intramuscular use of betamethasone sodium phosphate and betamethasone acetate injectable suspension is indicated as follows: allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. dermatologic diseases bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). endocrine disorders congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis. hydrocortisone or cortisone is the drug of choice in primary or secondary adrenocortical insufficiency.  synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance. gastrointesti

USA - engelska - NLM (National Library of Medicine)

american regent, inc. - betamethasone acetate (unii: ti05ao53l7) (betamethasone - unii:9842x06q6m), betamethasone sodium phosphate (unii: 7bk02scl3w) (betamethasone - unii:9842x06q6m) - when oral therapy is not feasible, the intramuscular use of betamethasone sodium phosphate and betamethasone acetate injectable suspension is indicated as follows: allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. dermatologic diseases bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). endocrine disorders congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis. hydrocortisone or cortisone is the drug of choice in primary or secondary adrenocortical insufficiency.  synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance. gastrointesti

USA - engelska - NLM (National Library of Medicine)

american regent, inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - sodium chloride 9 mg in 1 ml - intravenous solutions containing sodium chloride are indicated for parenteral replenishment of fluid and sodium chloride as required by the clinical condition of the patient. none known.

USA - engelska - NLM (National Library of Medicine)

american regent, inc. - water (unii: 059qf0ko0r) (water - unii:059qf0ko0r) - water 1 ml in 1 ml - sterile water for injection, usp is water for injection sterilized and packaged in single dose vials. it contains no antimicrobial agents or other preservatives. it is used as a diluent. non-pyrogenic.

USA - engelska - NLM (National Library of Medicine)

american regent, inc. - sodium acetate anhydrous (unii: nvg71zz7p0) (acetate ion - unii:569dqm74sc, sodium cation - unii:lyr4m0nh37) - sodium acetate anhydrous 328 mg in 1 ml - sodium acetate for injection, usp concentrate is indicated as a source of sodium in patients with restricted or no oral intake. it is also useful as an additive for preparing specific intravenous fluid formulas, when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. sodium acetate for injection, usp concentrate is contraindicated in patients with hypernatremia.